Abbott LaboratoriesvsU.S. Physical Therapy

ABT and USPH stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$108.52

Value $189B

+1.18%
ABT's page

USPH

U.S. Physical Therapy, Inc.

$99.60

Value $1.5B

+1.01%
USPH's page

Abbott Laboratories (ABT) has a market value of $189B and U.S. Physical Therapy (USPH) $1.5B. Over the last year, with dividends, ABT moved -13.7% and USPH +40.9%. The P/E is 40.1 for ABT and 50.0 for USPH. Dividend yield: ABT 2.32%, USPH 1.84%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$189B

    USPH$1.5B

    ABT is 125 times USPH

  • Revenue, 12 months

    ABT$48.2B

    USPH$838M

    ABT is 58 times USPH

  • Net income, 12 months

    ABT$4.7B

    USPH$30M

    ABT is 156 times USPH

  • Operating margin

    ABT13.8%

    USPH9.1%

    4.7 points apart

  • ROIC

    ABT6.3%

    USPH8.6%

    2.4 points apart

  • P/E

    ABT40.1

    USPH50.0

    USPH is 1.2 times ABT

  • Dividend yield

    ABT2.3%

    USPH1.8%

    0.5 points apart

  • 5-year return

    ABT-6.7%

    USPH+10.0%

    16.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-6.7%

USPH+10.0%

8010012020222023202420252026
Returns by period
PeriodABTWith dividendsUSPHWith dividends
1 year since November 12, 2025-13.7%Price -15.8%+40.9%Price +37.3%
3 years since November 13, 2023+20.7%+6.5% a yearPrice +13.3%+29.3%+8.9% a yearPrice +21.0%
5 years since November 12, 2021-6.7%-1.4% a yearPrice -15.5%+10.0%+1.9% a yearPrice -0.1%
10 years since November 15, 2016+228.9%+12.6% a yearPrice +172.6%+86.3%+6.4% a yearPrice +60.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesUSPHU.S. Physical Therapy

Valuation

ABTUSPH
Valuation
Price$108.52$99.60
Market value$189B$1.5B
Enterprise value (EV)$215B$1.7B
P/E40.150.0
P/E, 5-year median33.748.2
P/B3.73.5
EV/EBIT32.422.5
Free cash flow yield3.6%4.6%

Results and growth

ABTUSPH
Results and growth
Revenue, 12 months$48.2B$838M
Net income, 12 months$4.7B$30M
Free cash flow, 12 months$6.8B$69M
Earnings per share, 12 months$2.69-$1.34
Revenue growth, year on year5.7%16.3%
Revenue growth a year, past+5.1%over 5 years+13.1%over 5 years
EPS growth a year, past+8.3%over 5 years-10.5%over 5 years

Margins and returns on capital

ABTUSPH
Margins and returns on capital
Gross margin56.9%18.9%
Operating margin13.8%9.1%
Net margin9.8%3.6%
ROIC6.3%8.6%
ROE9.1%6.5%

Balance sheet

ABTUSPH
Balance sheet
Cash$4.3B$38M
Total debt$31.2B$420M
Net debt / EBITDA3.32.1
Interest cover6.7×–

Dividends and buybacks

ABTUSPH
Dividends and buybacks
Dividend yield2.3%1.8%
Dividend per share, 12 months$2.52$1.83
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%0.4%
Shareholder yield2.8%2.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or USPH

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or U.S. Physical Therapy?

By market value, Abbott Laboratories ($189B) is about 125.2 times U.S. Physical Therapy ($1.5B), at today's prices.

How did ABT and USPH stock do over the last 10 years?

Since November 15, 2016, ABT's price moved +172.6% and USPH's +60.6%. With dividends: ABT +228.9% (+12.6% a year), USPH +86.3% (+6.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or USPH?

The dividend yield at today's price is 2.32% for Abbott Laboratories and 1.84% for U.S. Physical Therapy. Over the last twelve months they paid $2.52 and $1.83 per share.

What is the P/E of ABT and USPH?

At today's price, the P/E is 40.1 for ABT and 50.0 for USPH. The median of the last five years was 33.7 and 48.2, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or U.S. Physical Therapy?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 3.6% for U.S. Physical Therapy, and the operating margin 13.8% and 9.1%. Revenue was $48.2B and $838M.

Which is the better investment, Abbott Laboratories or U.S. Physical Therapy?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.